Want to join the conversation?
$CELG's sales from Otezla for 3Q15 increased by $121.1MM from last year, reflecting net sales of $128.4MM in the U.S. and $10.3MM in international markets. Sales from Abraxane rose by 8.3%, primarily due to increased unit volumes in international markets.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.